History of Centre for Inflammation Biology and Cancer Immunology
(Professor Adrian Hayday, Professor Michael Malim, Professor Leonie Taams Professor Richard Trembath, Professor Peter Parker and President & Principal Professor Ed Byrne, photo taken at official opening October 2018)
The Centre for Inflammation Biology and Cancer Immunology (CIBCI) was originally established as the Centre for Molecular and Cellular Biology of Inflammation (CMCBI) in 2009 under the scientific leadership of Prof Frederic Geissmann in a new laboratory space in King's College London with the support of Arthritis Research UK.
The official opening took place in June 2011 and was attended by Peter Hewitt (Chief Executive of Guy's and St Thomas' Charity), Professor Adrian Hayday (Head of DIIID, School of Medicine, KCL, 2003-2013), Professor Robert Lechler (Vice-Principal (Health) and Executive Director of King’s Health Partners Academic Health Sciences Centre), Professor Frederic Geissmann (Director of the CMCBI, 2009-2015) and Professor Alan Silman (Medical Director for Arthritis Research UK, 2007-2014).
In 2016, the Centre became the Centre for Inflammation Biology and Cancer Immunology (CIBCI) to reflect King’s College London expanding research interests in tumour immunobiology and the relationship between inflammation and cancer development.CIBCI is part of the School of Immunology & Microbial Sciences within the Faculty of Life Sciences & Medicine, King's College London.
(President & Principal Professor Ed Byrne and Professor Leonie Taams unveiling the CIBCI plaque at the launch in October 2018)
The Centre was officially launched in October 2018, read more about this here.